Nucleotide analogues
Grant
US12582656B2
Kind: B2
Mar 24, 2026
Assignee
R.G.C.C. Holdings AG
Inventors
Ioannis Papasotiriou
Abstract
A compound according to the formula I for use in the treatment of coronavirus infection and/or a respiratory disease caused by a coronavirus, wherein R1 is chosen from alkoxy groups such as for example methoxy or ethoxy, hydroxyl group, and phosphate group,wherein R2 is a group chosen from halogen and/or hydrogen,wherein Y is a nucleic base, preferably a purine or pyrimidine.
CPC Classifications
A61K 31/517
A61P 31/14
A61P 11/00
Filing Date
2021-03-23
Application No.
17914634
Claims
6